Daily Liposomal Amphotericin B Noninferior To Daily Amphotericin B Deoxycholate When Combined With Adjunctive Flucytosine For Treating HIV-Associated Cryptococcal Meningitis, Study Shows

Infectious Disease Advisor (8/5, Nye) reports, “For HIV-associated cryptococcal meningitis, daily liposomal amphotericin B is noninferior to daily amphotericin B deoxycholate when combined with adjunctive flucytosine, according to” a study. Researchers came to this conclusion after pooling “data from 3 overlapping prospective clinical trials conducted in Uganda between 2017 and 2023 among patients with HIV-associated cryptococcal meningitis.” The findings were published in Clinical Infectious Diseases.